Six years after COVID-19 reshaped the world, researchers at UCLA have illuminated a hidden mechanism behind the virus's most enduring harms — one residing not in the celebrated spike protein, but in the quieter nucleocapsid protein that packages the virus's genetic material. This protein, it turns out, plays both sides of the immune battlefield: silencing the body's early warnings while later stoking a dangerous inflammatory fire inside the very cells meant to protect us. The discovery offers not only a more complete portrait of how COVID-19 damages the heart and brain, but a potential map tow
UCLA study reveals how SARS-CoV-2 nucleocapsid protein triggers dangerous immune overreaction
Long COVID patients experience ongoing complications from tissue damage caused by hyperinflammatory immune responses triggered by viral proteins.
The virus dampens early, then overactivates later—that's when tissue damage happens.
Mark
Why has the nucleocapsid protein been overlooked for so long if it's this important?
Mimi
The spike protein is what the virus uses to enter cells, so it became the obvious target for vaccines and public attention. The nucleocapsid protein does quieter work—packaging genetic material—so it didn't draw the same focus, even though it's present in every infected cell.
Mark
So the virus is essentially sabotaging its own ability to spread by triggering this inflammation?
Mimi
Exactly. The researchers think it's an unintended consequence. The virus wants to replicate and spread, not make its host severely ill. But by suppressing early defenses and then amplifying inflammation, it inadvertently creates conditions that damage the very tissues it needs to survive in.
Mark
Why did the delta variant's nucleocapsid protein cause more inflammation than others?
Mimi
That's still an open question. It suggests the virus evolved in ways that made this particular protein more inflammatory, though whether that was adaptive or just a side effect of other mutations isn't clear yet.
Mark
Could this explain why some people get long COVID and others don't?
Mimi
It's part of the picture. Individual differences in immune response, viral load, and genetics all matter. But understanding this mechanism gives us a target—if we can control how the nucleocapsid protein activates macrophages, we might prevent the cascade of damage that leads to long-term complications.
Mark
What would a nucleocapsid-targeted vaccine look like?
Mimi
Instead of just training the immune system to recognize and destroy the spike protein, it would also teach the body to neutralize or clear the nucleocapsid protein before it can trigger macrophage overactivation. That's more complex, but potentially more protective against severe disease.
The Pulse
- Long COVID patients and those with severe disease have lacked a clear explanation for why the virus so reliably injures the heart and brain — and existing treatments have been too blunt to address the underlying cause.
- UCLA researchers found that the nucleocapsid protein suppresses early immune defenses to help the virus spread, then triggers a dangerous overreaction in macrophages that can rupture the barriers protecting vital organs.
- Laboratory models of the blood-brain barrier and coronary artery lining showed that inflammatory signals from macrophages — especially those responding to the delta variant's nucleocapsid protein — caused significant breakdown in the heart's vascular barrier.
- The delta variant's nucleocapsid protein proved the most inflammatory of all variants and related coronaviruses tested, underscoring why that wave produced such severe outcomes.
- The findings point toward nucleocapsid-targeted vaccines and precision therapies that could replace broad corticosteroids, offering new hope for long COVID sufferers and immunocompromised patients with few current options.
Six years after COVID-19 reshaped the world, researchers at UCLA have illuminated a hidden mechanism behind the virus's most enduring harms — one residing not in the celebrated spike protein, but in the quieter nucleocapsid protein that packages the virus's genetic material. This protein, it turns out, plays both sides of the immune battlefield: silencing the body's early warnings while later stoking a dangerous inflammatory fire inside the very cells meant to protect us. The discovery offers not only a more complete portrait of how COVID-19 damages the heart and brain, but a potential map toward therapies precise enough to spare patients the blunt costs of broad immune suppression.
Six years after the pandemic, UCLA researchers have identified a mechanism behind some of COVID-19's most severe and lasting damage — and it centers on a protein that has lived largely in the spike protein's shadow. The nucleocapsid protein, which encases the virus's genetic material, was already known to suppress early immune responses, buying the pathogen time to establish itself. But virologist Melody Li and her team discovered something more unsettling: the protein also amplifies dangerous inflammation inside macrophages, the immune cells that patrol tissues and coordinate the body's defenses. It suppresses the alarm, then fans the fire.
Testing nucleocapsid proteins from multiple SARS-CoV-2 variants as well as from SARS-CoV-1 and MERS, the researchers found this pro-inflammatory effect consistent across all pathogenic coronaviruses studied. The delta variant's version proved the most inflammatory of all. To trace how this macrophage overactivation might harm vital organs, the team built human cell models of the blood-brain barrier and the coronary artery lining — the tightly sealed endothelial structures that control what enters the brain and heart from the bloodstream. When exposed to inflammatory signals from macrophages producing the delta variant's nucleocapsid protein, the cardiac barrier broke down significantly, offering a plausible mechanism for the heart injury documented in severe COVID-19 cases.
The implications reach well beyond explaining past harm. Current treatment for severe COVID-19 relies on broad anti-inflammatory drugs like corticosteroids, which suppress inflammation generally without targeting the viral mechanisms driving it. A therapy or vaccine aimed specifically at the nucleocapsid protein could offer far more precise protection for the vascular barriers that sustain brain and heart function. Because macrophages play similarly double-edged roles in many other infections, the mechanism may prove relevant across a wider landscape of disease — and for long COVID patients still living with the consequences of the immune system's overreaction, it suggests that more targeted pathways forward may finally be within reach.
Six years into the aftermath of the COVID-19 pandemic, researchers at UCLA have identified a mechanism that helps explain why the virus causes such severe damage to the heart and brain in some patients—and it involves a protein that has received far less attention than the famous spike protein that dominates vaccine development.
The nucleocapsid protein, which serves as the virus's packaging material, has long been known to suppress the body's early antiviral defenses, giving the pathogen time to establish itself. Scientists led by virologist Melody Li wanted to understand whether SARS-CoV-2's version of this protein worked the same way as the nucleocapsid proteins found in SARS and MERS, the earlier coronaviruses that also caused severe illness. What they discovered instead was something unexpected: the protein acts as a double-edged sword. While it does dampen the initial immune alarm, it simultaneously amplifies inflammatory pathways inside macrophages—the immune cells that patrol tissues looking for signs of infection and release chemical signals to mobilize the body's defenses.
This finding reframes a central puzzle of COVID-19 pathology. The virus appears to suppress immune responses early in infection, allowing it to spread, then triggers a dangerous overreaction later that causes much of the tissue damage. The nucleocapsid protein, it turns out, plays a role in both phases. When the researchers tested the protein from multiple SARS-CoV-2 variants as well as from SARS-CoV-1 and MERS-CoV, they found this pro-inflammatory effect was consistent across all pathogenic coronaviruses tested. The delta variant's nucleocapsid protein proved by far the most inflammatory of all.
To understand how this macrophage overactivation might harm the body's vital organs, Li's team built two human cell-based models: one mimicking the blood-brain barrier and another modeling the lining of coronary arteries. These barriers are made of endothelial cells that control what passes from the bloodstream into surrounding tissues. The brain's barrier is especially tightly sealed, protecting delicate neural tissue from pathogens and toxins. When the researchers exposed both models to inflammatory signals released by macrophages producing the delta variant's nucleocapsid protein, the heart barrier broke down significantly—a phenomenon called vascular leakage. The brain barrier remained more resilient, but the cardiac findings point to a possible mechanism explaining the heart injury documented in severe COVID-19 cases.
The implications for treatment are substantial. Severe COVID-19 is currently managed with broad anti-inflammatory drugs like corticosteroids, which dampen harmful inflammation generally but do not specifically target the viral mechanisms driving it. A therapy or vaccine designed to target the nucleocapsid protein could potentially control hyperinflammation more precisely and protect the blood vessel barriers that support brain and heart function. Because macrophages play similar double-edged roles in many other infections, the same mechanism may prove relevant far beyond this single virus. For patients with long COVID—those experiencing ongoing complications from tissue damage caused by the immune system's overreaction—and for immunocompromised individuals with limited treatment options, these findings suggest new pathways forward.
Notable Quotes
We set out looking for a protein that suppresses the immune response, and we found the opposite.— Zhenlan Yao, co-first author of the study
It's a bit like a thief trying to slip past a bank's security system, but instead of staying quiet, it trips the alarm.— Melody Li, lead researcher
Want the full story?
Read the original at Medical Xpress ↗
Health & Medicine